Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Aug 2008 for Protagenic Therapeutics, Inc.\new.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Andrew Stollman: trading record in brief
Andrew Stollman discloses dealings in 2 companies, chiefly Protagenic Therapeutics, Inc.\new and Traffix Inc. The record holds 2 filings, all for trades on 4 February 2008.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 7 August 2008 came the latest disclosure, a transaction in Protagenic Therapeutics, Inc.\new. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Stollman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
443,085 sharesCommon StockSEC:0001144204-08-044465:0
655,382 sharesCommon StockSEC:0001144204-08-006873:0
2 of 2 declarations
